Cover Image

Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage])

Saved in:
Bibliographic Details
Main Authors: Hänggi, Daniel (Author) , Etminan, Nima (Author) , Steiger, Hans-Jakob (Author) , Mayer, Stephan A. (Author) , Macdonald, Robert Loch (Author)
Format: Article (Journal)
Language:English
Published: 2017
In: Stroke
Year: 2017, Volume: 48, Issue: 1, Pages: 145-151
ISSN:1524-4628
DOI:10.1161/STROKEAHA.116.014250
Online Access:Verlag, kostenfrei, Volltext: https://www.ncbi.nlm.nih.gov/pubmed/27932607
Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1161/STROKEAHA.116.014250
Get full text
Author Notes:Daniel Hänggi, Nima Etminan, Francois Aldrich, Hans Jakob Steiger, Stephan A. Mayer, Michael N. Diringer, Brian L. Hoh, J. Mocco, Herbert J. Faleck, R. Loch Macdonald
Description
Item Description:Originally published December 8, 2016
Gesehen am 04.10.2018
Physical Description:Online Resource
ISSN:1524-4628
DOI:10.1161/STROKEAHA.116.014250

Similar Items